Single-voxel 1H spectroscopy in the human hippocampus at 3 T using the LASER sequence: Characterization of neurochemical profile and reproducibility

NMR in Biomedicine

Volumn 28, Issue 10, 2015, Pages 1209-1217

  Allaïli, Najib ^a,b,c,d,e   Valabrègue, Romain ^a,b,c   Auerbach, Edward J ^f   Guillemot, Vincent ^a,b,c,g   Yahia Cherif, Lydia ^a,b,c   Bardinet, Eric ^a,b,c   Jabourian, Maritza ^h   Fossati, Philippe ⁱ   Lehéricy, Stéphane ^a,b,c,i   Marjańska, Małgorzata ^f  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY OF MINNESOTA   (United States)

^g ICM   (France)

^h INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

3 T; CV; Glutamate; Glutamine; Hippocampus; ICC; MRS reproducibility; Sensitivity

Indexed keywords

AMINO ACIDS; LIGHT POLARIZATION; METABOLITES; NEURODEGENERATIVE DISEASES;

GLUTAMATE; GLUTAMINE; HIPPOCAMPUS; REPRODUCIBILITIES; SENSITIVITY;

BRAIN;

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; LACTIC ACID DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LASER; MALE; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAHIPPOCAMPAL GYRUS; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; ANALOGS AND DERIVATIVES; CHEMISTRY; DEVICES; FEASIBILITY STUDY; PROCEDURES; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; FEASIBILITY STUDIES; FEMALE; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; LACTATES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84941736796     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3364     Document Type: Article

References (52)

1. Bird CM, Burgess N. The hippocampus and memory: insights from spatial processing. Nat. Rev. Neurosci. 2008; 9(3): 182-194.
2. Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci. 2010; 11(5): 339-350.
3. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011; 12(10): 585-601.
4. Jack CR, Jr. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 2012; 263(2): 344-361.
5. Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration - predicting molecular pathology. Nat. Rev. Neurol. 2012; 8(3): 131-142.
6. Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 2012; 135(1): 170-180.
7. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 2004; 161(4): 598-607.
8. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004; 161(11): 1957-1966.
9. Bartha R, Al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, Densmore M, Canaran G, Neufeld RW. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol. Psychiatry 1999; 45(11): 1403-1411.
10. 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann. Neurol. 1999; 45(3): 369-376.
11. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997; 49(6): 1513-1521.
12. Kantarci K, Jack CR, Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000; 55(2): 210-217.
13. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 2000; 355(9216): 1696-1697.
14. 1H MRS of the hippocampus after donepezil treatment in Alzheimer disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32(3): 786-793.
15. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 2012; 13(1): 22-37.
16. Yuksel C, Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol. Psychiatry 2010; 68(9): 785-794.
17. Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn. Reson. Med. 1999; 41(1): 204-207.
18. 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. J. Magn. Reson. Imaging 2004; 20(3): 366-371.
19. 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla - how reproducible are the results? NMR Biomed. 2005; 18(3): 195-201.
20. 1H PRESS at 4.0 T: precision and variability of measurements in anterior cingulate and hippocampus. NMR Biomed. 2006; 19(4): 484-491.
21. Kassem MN, Bartha R. Quantitative proton short-echo-time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction. Magn. Reson. Med. 2003; 49(5): 918-927.
22. Hsu YY, Chen MC, Lim KE, Chang C. Reproducibility of hippocampal single-voxel proton MR spectroscopy and chemical shift imaging. Am. J. Roentgenol. 2001; 176(2): 529-536.
23. 1H MRS brain metabolite concentrations in vivo. Magn. Reson. Imaging 2003; 21(7): 787-797.
24. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 2001; 153(2): 155-177.
25. 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn. Reson. Med. 1999; 41(4): 649-656.
26. 1 magnitude. J. Magn. Reson. 1988; 80(3): 448-469.
27. Silver M, Joseph R, Hoult D. Highly selective π/2 and π pulse generation. J. Magn. Reson. 1984; 59(2): 347-351.
28. Gruetter R, Tkac I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn. Reson. Med. 2000; 43(2): 319-323.
29. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30(6): 672-679.
30. Henry PG, Marjanska M, Walls JD, Valette J, Gruetter R, Ugurbil K. Proton-observed carbon-edited NMR spectroscopy in strongly coupled second-order spin systems. Magn. Reson. Med. 2006; 55(2): 250-257.
31. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3): 129-153.
32. 1H MRS study at 7 Tesla in the occipital lobe. Magn. Reson. Med. 2014; 72(4): 934-940.
33. Snoussi K, Gillen JS, Horska A, Puts NA, Pradhan S, Edden RA, Barker PB. Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla. Magn. Reson. Med. 2014. DOI: 10.1002/mrm.25468
34. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, Posse S, Jung RE, Morrison LA. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn. Reson. Med. 2006; 55(6): 1219-1226.
35. 2 relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001; 14(5): 325-331.
36. Wansapura JP, Holland SK, Dunn RS, Ball WS, Jr. NMR relaxation times in the human brain at 3.0 tesla. J. Magn. Reson. Imaging 1999; 9(4): 531-538.
37. † measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn. Reson. Med. 2002; 47(4): 742-750.
38. 2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn. Reson. Med. 2002; 47(4): 629-633.
39. Deelchand DK, Adanyeguh IM, Emir UE, Nguyen TM, Valabregue R, Henry PG, Mochel F, Oz G. Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T. Magn. Reson. Med. 2015; 73(5): 1718-1725.
40. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J. Strength Cond. Res. 2005; 19(1): 231-240.
41. 1H-MRS measurements in schizophrenic patients. Magn. Reson. Med. 2003; 50(4): 704-707.
42. 1H-MRS in vivo. Magn. Reson. Med. 1999; 41(1): 193-197.
43. Deelchand DK, Henry PG, Marjanska M. Effect of Carr-Purcell refocusing pulse trains on transverse relaxation times of metabolites in rat brain at 9.4 Tesla. Magn. Reson. Med. 2014. DOI: 10.1002/mrm.25088
44. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004; 21(4): 1762-1771.
45. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J. Magn. Reson. 2004; 19(5): 537-545.
46. de Graaf RA. In Vivo NMR Spectroscopy. Principles and Techniques. Wiley: Chichester, England, 2007.
47. Nacewicz BM, Angelos L, Dalton KM, Fischer R, Anderle MJ, Alexander AL, Davidson RJ. Reliable non-invasive measurement of human neurochemistry using proton spectroscopy with an anatomically defined amygdala-specific voxel. Neuroimage 2012; 59(3): 2548-2559.
48. Cendes F, Caramanos Z, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann. Neurol. 1997; 42(5): 737-746.
49. 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn. Reson. Imaging 1998; 16(8): 969-979.
50. 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005; 30(11): 1949-1962.
51. 1H-MRS at 0.5 T. Neurology 2001; 56(6): 737-742.
52. Hattori N, Abe K, Sakoda S, Sawada T. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease. Neuroreport 2002; 13(1): 183-186.